Somatic Mutations and Clonal Hematopoiesis as Drivers of Age-Related Cardiovascular Risk
暂无分享,去创建一个
[1] B. Ebert,et al. Genetics of smoking and risk of clonal hematopoiesis , 2022, Scientific Reports.
[2] Aviv Madar,et al. TET2-Driven Clonal Hematopoiesis and Response to Canakinumab: An Exploratory Analysis of the CANTOS Randomized Clinical Trial. , 2022, JAMA cardiology.
[3] Andrew D. Johnson,et al. Clonal Hematopoiesis Is Associated With Higher Risk of Stroke , 2021, Stroke.
[4] Sina A. Gharib,et al. Association of clonal hematopoiesis with chronic obstructive pulmonary disease , 2021, Blood.
[5] A. Bick,et al. Clonal Hematopoiesis of Indeterminate Potential: an Expanding Genetic Cause of Cardiovascular Disease , 2021, Current Atherosclerosis Reports.
[6] S. Asada,et al. Clonal hematopoiesis and associated diseases: A review of recent findings , 2021, Cancer science.
[7] P. Natarajan,et al. Clonal hematopoiesis of indeterminate potential (CHIP): Linking somatic mutations, hematopoiesis, chronic inflammation and cardiovascular disease. , 2021, Journal of molecular and cellular cardiology.
[8] J. Manson,et al. Supplemental Association of Clonal Hematopoiesis With Incident Heart Failure. , 2021, Journal of the American College of Cardiology.
[9] P. Libby,et al. Association of Diet Quality With Prevalence of Clonal Hematopoiesis and Adverse Cardiovascular Events. , 2021, JAMA cardiology.
[10] S. Dawson,et al. HIV is associated with an increased risk of age-related clonal hematopoiesis among older adults , 2021, Nature Medicine.
[11] A. Dopazo,et al. Clonal Hematopoiesis and Risk of Progression of Heart Failure With Reduced Left Ventricular Ejection Fraction. , 2021, Journal of the American College of Cardiology.
[12] J. Manson,et al. Healthy Lifestyle and Clonal Hematopoiesis of Indeterminate Potential: Results From the Women's Health Initiative , 2021, Journal of the American Heart Association.
[13] Johannes G. Reiter,et al. Increased stem cell proliferation in atherosclerosis accelerates clonal hematopoiesis , 2021, Cell.
[14] A. Zeiher,et al. Clonal haematopoiesis in chronic ischaemic heart failure: prognostic role of clone size for DNMT3A- and TET2-driver gene mutations. , 2020, European heart journal.
[15] Francine E. Garrett-Bakelman,et al. Clonal Hematopoiesis Before, During, and After Human Spaceflight , 2020, Cell reports.
[16] E. Boerwinkle,et al. Increased CHIP Prevalence Amongst People Living with HIV , 2020, medRxiv.
[17] Maya N. Polackal,et al. TET2-Loss-of-Function-Driven Clonal Hematopoiesis Exacerbates Experimental Insulin Resistance in Aging and Obesity , 2020, Cell reports.
[18] Stuart M. Gardos,et al. Cancer therapy shapes the fitness landscape of clonal hematopoiesis , 2020, Nature Genetics.
[19] J. Manson,et al. Premature Menopause, Clonal Hematopoiesis, and Coronary Artery Disease in Postmenopausal Women , 2020, Circulation.
[20] Ivana V. Yang,et al. Inherited Causes of Clonal Hematopoiesis in 97,691 TOPMed Whole Genomes , 2020, Nature.
[21] G. Campo,et al. Translating Evidence from Clonal Hematopoiesis to Cardiovascular Disease: A Systematic Review , 2020, Journal of clinical medicine.
[22] A. Zeiher,et al. Association of Clonal Hematopoiesis of Indeterminate Potential With Inflammatory Gene Expression in Patients With Severe Degenerative Aortic Valve Stenosis or Chronic Postischemic Heart Failure. , 2020, JAMA cardiology.
[23] A. Zeiher,et al. Multiple Somatic Mutations for Clonal Hematopoiesis Are Associated with Increased Mortality in Patients with Chronic Heart Failure. , 2020, Circulation. Genomic and precision medicine.
[24] S. Mccarroll,et al. Chromosomal alterations among age-related haematopoietic clones in Japan , 2020, Nature.
[25] W. Tapper,et al. Clonal myelopoiesis in the UK Biobank cohort: ASXL1 mutations are strongly associated with smoking , 2020, Leukemia.
[26] P. Libby,et al. The Clinical Challenge of Clonal Hematopoiesis, a Newly Recognized Cardiovascular Risk Factor. , 2020, JAMA cardiology.
[27] R. Vasan,et al. Association of the Duration of Ideal Cardiovascular Health Through Adulthood With Cardiometabolic Outcomes and Mortality in the Framingham Offspring Study. , 2020, JAMA cardiology.
[28] An Pan,et al. Healthy lifestyle and life expectancy free of cancer, cardiovascular disease, and type 2 diabetes: prospective cohort study , 2020, BMJ.
[29] R. Diaz,et al. Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction. , 2019, The New England journal of medicine.
[30] S. Gabriel,et al. Genetic Interleukin 6 Signaling Deficiency Attenuates Cardiovascular Risk in Clonal Hematopoiesis , 2019, Circulation.
[31] A. Zeiher,et al. Hematopoietic alterations in chronic heart failure patients by somatic mutations leading to clonal hematopoiesis , 2019, Haematologica.
[32] B. Ebert,et al. Clonal hematopoiesis in human aging and disease , 2019, Science.
[33] P. S. St George-Hyslop,et al. TET2 Regulates the Neuroinflammatory Response in Microglia. , 2019, Cell reports.
[34] S. Fichtlscherer,et al. Clonal haematopoiesis in patients with degenerative aortic valve stenosis undergoing transcatheter aortic valve implantation , 2019, European heart journal.
[35] A. Murphy,et al. Hematopoiesis is regulated by cholesterol efflux pathways and lipid rafts: connections with cardiovascular diseases , 2019, Journal of Lipid Research.
[36] S. Kathiresan,et al. Clonal Hematopoiesis of Indeterminate Potential Reshapes Age-Related CVD: JACC Review Topic of the Week. , 2019, Journal of the American College of Cardiology.
[37] P. Libby,et al. Clonal Hematopoiesis: Crossroads of Aging, Cardiovascular Disease, and Cancer: JACC Review Topic of the Week. , 2019, Journal of the American College of Cardiology.
[38] S. Mccarroll,et al. Monogenic and polygenic inheritance become instruments for clonal selection , 2019, bioRxiv.
[39] A. Tantiworawit,et al. Alteration of SF3B1 and SRSF2 Genes in Myelodysplastic Syndromes Patients in Upper Northern Thailand , 2019, Asian Pacific journal of cancer prevention : APJCP.
[40] J. Moslehi,et al. Connections Between Clonal Hematopoiesis, Cardiovascular Disease, and Cancer: A Review , 2019, JAMA cardiology.
[41] B. Brüne,et al. Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure , 2018, JAMA cardiology.
[42] S. Jaiswal,et al. Clonal hematopoiesis: Pre‐cancer PLUS , 2019, Advances in cancer research.
[43] D. Steensma. Clinical consequences of clonal hematopoiesis of indeterminate potential. , 2018, Blood advances.
[44] A. Tall,et al. Macrophage Inflammation, Erythrophagocytosis, and Accelerated Atherosclerosis in Jak2V617F Mice , 2018, Circulation research.
[45] P. A. Futreal,et al. PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic Chemotherapy , 2018, Cell stem cell.
[46] B. Ebert,et al. Synthetic Lethal and Convergent Biological Effects of Cancer-Associated Spliceosomal Gene Mutations. , 2018, Cancer cell.
[47] M. Dubé,et al. Lineage restriction analyses in CHIP indicate myeloid bias for TET2 and multipotent stem cell origin for DNMT3A. , 2018, Blood.
[48] Fei Lan,et al. Glucose-regulated phosphorylation of TET2 by AMPK reveals a pathway linking diabetes to cancer , 2018, Nature.
[49] P. Libby,et al. Clonal Hematopoiesis Confers Predisposition to Both Cardiovascular Disease and Cancer: A Newly Recognized Link Between Two Major Killers , 2018, Annals of Internal Medicine.
[50] Yakir A Reshef,et al. Insights about clonal hematopoiesis from 8,342 mosaic chromosomal alterations , 2018, Nature.
[51] K. Walsh,et al. CRISPR-Mediated Gene Editing to Assess the Roles of Tet2 and Dnmt3a in Clonal Hematopoiesis and Cardiovascular Disease , 2018, Circulation research.
[52] S. Mccarroll,et al. Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms , 2018, Science Translational Medicine.
[53] D. Goukassian,et al. Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1β/NLRP3 Inflammasome. , 2018, Journal of the American College of Cardiology.
[54] A. Gotoh,et al. Mutational subtypes of JAK2 and CALR correlate with different clinical features in Japanese patients with myeloproliferative neoplasms , 2018, International Journal of Hematology.
[55] L. Shlush. Age-related clonal hematopoiesis. , 2018, Blood.
[56] Jie Gong,et al. The NLRP3 Inflammasome: An Important Driver of Neuroinflammation in Hemorrhagic Stroke , 2017, Cellular and Molecular Neurobiology.
[57] C. Ling,et al. Dnmt3a is an epigenetic mediator of adipose insulin resistance , 2017, eLife.
[58] O. Abdel-Wahab,et al. Restoration of TET2 Function Blocks Aberrant Self-Renewal and Leukemia Progression , 2017, Cell.
[59] Timothy Chevassut,et al. Clonal Hematopoiesis and Atherosclerosis. , 2017, The New England journal of medicine.
[60] P. Libby,et al. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease , 2017, The New England journal of medicine.
[61] Kari Stefansson,et al. Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly. , 2017, Blood.
[62] S. Gabriel,et al. Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease , 2017, The New England journal of medicine.
[63] A. Scialdone,et al. Adipocyte Accumulation in the Bone Marrow during Obesity and Aging Impairs Stem Cell-Based Hematopoietic and Bone Regeneration , 2017, Cell stem cell.
[64] Matthew A. Cooper,et al. Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice , 2017, Science.
[65] Max Jan,et al. Clonal hematopoiesis. , 2017, Seminars in hematology.
[66] A. Yoshimura,et al. Adiponectin Enhances Antibacterial Activity of Hematopoietic Cells by Suppressing Bone Marrow Inflammation. , 2016, Immunity.
[67] M. McCarthy,et al. Age-related clonal hematopoiesis associated with adverse outcomes. , 2014, The New England journal of medicine.
[68] S. Gabriel,et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. , 2014, The New England journal of medicine.
[69] E. Riboli,et al. Association between large detectable clonal mosaicism and type 2 diabetes with vascular complications , 2013, Nature Genetics.
[70] D. Mozaffarian,et al. Population Approaches to Improve Diet, Physical Activity, and Smoking Habits: A Scientific Statement From the American Heart Association , 2012, Circulation.
[71] E. Ford,et al. Healthy lifestyle behaviors and all-cause mortality among adults in the United States. , 2012, Preventive medicine.
[72] C. Ogilvy,et al. Specific TNF-alpha inhibition in cerebral aneurysm formation and subarachnoid hemorrhage. , 2012, Current drug safety.
[73] Ingo Ruczinski,et al. Detectable clonal mosaicism from birth to old age and its relationship to cancer , 2012, Nature Genetics.
[74] François Mach,et al. Inflammation and Atherosclerosis , 2004, Herz.
[75] P. Libby,et al. Inflammation and Atherosclerosis , 2002, Circulation.
[76] A. Cumano,et al. Jak2 Deficiency Defines an EssentialDevelopmental Checkpoint in DefinitiveHematopoiesis , 1998, Cell.